Lowering fecal immunochemical test positivity threshold vs multitarget stool RNA testing for colorectal cancer screening
Fecal immunochemical tests (FITs) for hemoglobin are the most widely used screening tests for colorectal cancer (CRC) globally. However, they have limited sensitivity in detecting early-stage CRC and CRC precursors. In 2023, the CRC-PREVENT study, a blinded, prospective, cross-sectional study that e...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Dokumenttyp: | Article (Journal) Editorial |
| Sprache: | Englisch |
| Veröffentlicht: |
June 1, 2004
|
| In: |
The journal of the American Medical Association
Year: 2024, Jahrgang: 332, Heft: 3, Pages: 251-252 |
| ISSN: | 1538-3598 |
| DOI: | 10.1001/jama.2024.9289 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1001/jama.2024.9289
|
| Verfasserangaben: | Tobias Niedermaier, Teresa Seum, Michael Hoffmeister, Hermann Brenner |
MARC
| LEADER | 00000caa a22000002c 4500 | ||
|---|---|---|---|
| 001 | 1913852652 | ||
| 003 | DE-627 | ||
| 005 | 20250918115850.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 250108s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1001/jama.2024.9289 |2 doi | |
| 035 | |a (DE-627)1913852652 | ||
| 035 | |a (DE-599)KXP1913852652 | ||
| 035 | |a (OCoLC)1528015868 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Niedermaier, Tobias |e VerfasserIn |0 (DE-588)1141256126 |0 (DE-627)899005861 |0 (DE-576)470310774 |4 aut | |
| 245 | 1 | 0 | |a Lowering fecal immunochemical test positivity threshold vs multitarget stool RNA testing for colorectal cancer screening |c Tobias Niedermaier, Teresa Seum, Michael Hoffmeister, Hermann Brenner |
| 264 | 1 | |c June 1, 2004 | |
| 300 | |a 2 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 08.01.2025 | ||
| 520 | |a Fecal immunochemical tests (FITs) for hemoglobin are the most widely used screening tests for colorectal cancer (CRC) globally. However, they have limited sensitivity in detecting early-stage CRC and CRC precursors. In 2023, the CRC-PREVENT study, a blinded, prospective, cross-sectional study that enrolled the target population for CRC screening, demonstrated increased sensitivity for CRC of a multitarget stool RNA (mt-sRNA) test compared with FIT alone (94% vs 78%). The mt-sRNA test incorporated a commercially available FIT (iFOBT OC-Auto; positivity threshold, 20 μg hemoglobin per gram of feces), concentration of 8 RNA transcripts, and participant-reported smoking status. However, this increase in sensitivity came at a substantial loss of specificity for no lesions compared with FIT alone (88% vs 96%). This analysis evaluated whether comparable levels of sensitivity and specificity could be achieved by lowering the FIT positivity threshold, without additional stool RNA testing and smoking assessment. | ||
| 700 | 1 | |a Seum, Teresa |e VerfasserIn |0 (DE-588)1357938993 |0 (DE-627)1918715122 |4 aut | |
| 700 | 1 | |a Hoffmeister, Michael |d 1973- |e VerfasserIn |0 (DE-588)134103726 |0 (DE-627)560880820 |0 (DE-576)277089565 |4 aut | |
| 700 | 1 | |a Brenner, Hermann |e VerfasserIn |0 (DE-588)1020516445 |0 (DE-627)691247005 |0 (DE-576)360642136 |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |a American Medical Association |t The journal of the American Medical Association |d Chicago, Ill. : American Medical Association, 1883 |g 332(2024), 3 vom: Juni, Seite 251-252 |h Online-Ressource |w (DE-627)316017000 |w (DE-600)2018410-4 |w (DE-576)091019974 |x 1538-3598 |7 nnas |
| 773 | 1 | 8 | |g volume:332 |g year:2024 |g number:3 |g month:06 |g pages:251-252 |g extent:2 |a Lowering fecal immunochemical test positivity threshold vs multitarget stool RNA testing for colorectal cancer screening |
| 856 | 4 | 0 | |u https://doi.org/10.1001/jama.2024.9289 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20250108 | ||
| 993 | |a Editorial | ||
| 994 | |a 2024 | ||
| 998 | |g 1020516445 |a Brenner, Hermann |m 1020516445:Brenner, Hermann |d 850000 |d 851600 |d 50000 |e 850000PB1020516445 |e 851600PB1020516445 |e 50000PB1020516445 |k 0/850000/ |k 1/850000/851600/ |k 0/50000/ |p 4 |y j | ||
| 998 | |g 134103726 |a Hoffmeister, Michael |m 134103726:Hoffmeister, Michael |d 50000 |e 50000PH134103726 |k 0/50000/ |p 3 | ||
| 998 | |g 1357938993 |a Seum, Teresa |m 1357938993:Seum, Teresa |d 50000 |e 50000PS1357938993 |k 0/50000/ |p 2 | ||
| 998 | |g 1141256126 |a Niedermaier, Tobias |m 1141256126:Niedermaier, Tobias |d 50000 |e 50000PN1141256126 |k 0/50000/ |p 1 |x j | ||
| 999 | |a KXP-PPN1913852652 |e 4647168565 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2024","dateIssuedDisp":"June 1, 2004"}],"title":[{"title":"Lowering fecal immunochemical test positivity threshold vs multitarget stool RNA testing for colorectal cancer screening","title_sort":"Lowering fecal immunochemical test positivity threshold vs multitarget stool RNA testing for colorectal cancer screening"}],"person":[{"display":"Niedermaier, Tobias","family":"Niedermaier","given":"Tobias","role":"aut"},{"role":"aut","display":"Seum, Teresa","family":"Seum","given":"Teresa"},{"given":"Michael","family":"Hoffmeister","display":"Hoffmeister, Michael","role":"aut"},{"given":"Hermann","family":"Brenner","display":"Brenner, Hermann","role":"aut"}],"note":["Gesehen am 08.01.2025"],"relHost":[{"language":["eng"],"disp":"American Medical AssociationThe journal of the American Medical Association","physDesc":[{"extent":"Online-Ressource"}],"part":{"year":"2024","issue":"3","text":"332(2024), 3 vom: Juni, Seite 251-252","volume":"332","pages":"251-252","extent":"2"},"corporate":[{"role":"aut","display":"American Medical Association"}],"titleAlt":[{"title":"JAMA"}],"recId":"316017000","id":{"issn":["1538-3598"],"zdb":["2018410-4"],"eki":["316017000"]},"note":["Gesehen am 23.08.2019"],"type":{"bibl":"periodical","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"1883","publisher":"American Medical Association","dateIssuedDisp":"1883-","publisherPlace":"Chicago, Ill."}],"title":[{"title":"The journal of the American Medical Association","title_sort":"journal of the American Medical Association","subtitle":"JAMA"}],"pubHistory":["1.1883 -"]}],"name":{"displayForm":["Tobias Niedermaier, Teresa Seum, Michael Hoffmeister, Hermann Brenner"]},"id":{"eki":["1913852652"],"doi":["10.1001/jama.2024.9289"]},"recId":"1913852652","language":["eng"],"physDesc":[{"extent":"2 S."}]} | ||
| SRT | |a NIEDERMAIELOWERINGFE1200 | ||